TSE:CRON

Cronos Group (CRON) Stock Price, News & Analysis

C$3.53
+0.09 (+2.62%)
(As of 04/26/2024 08:54 PM ET)
Today's Range
C$3.43
C$3.62
50-Day Range
C$2.62
C$3.89
52-Week Range
C$2.15
C$4.01
Volume
218,164 shs
Average Volume
207,861 shs
Market Capitalization
C$1.35 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$2.77
CRON stock logo

About Cronos Group Stock (TSE:CRON)

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

CRON Stock Price History

CRON Stock News Headlines

His win rate puts Warren Buffett to shame…
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
CRON Oct 2024 2.500 put
His win rate puts Warren Buffett to shame…
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
Cronos Group Inc CRON
Cronos Group Inc (CRON)
Cronos Enters Australian Cannabis Market
See More Headlines
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/29/2024
Next Earnings (Estimated)
5/07/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
356
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$2.77
High Stock Price Target
C$2.82
Low Stock Price Target
C$2.72
Potential Upside/Downside
-21.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
C$-69,850,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$87.24 million
Cash Flow
C$2.11 per share
Book Value
C$2.88 per share

Miscellaneous

Free Float
N/A
Market Cap
C$1.35 billion
Optionable
Not Optionable
Beta
1.04
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Michael Ryan Gorenstein J.D. (Age 37)
    President, CEO & Chairman
    Comp: $5.38M
  • Mr. James Holm (Age 41)
    Chief Financial Officer
    Comp: $429.32k
  • Mr. Jeffrey David Jacobson (Age 38)
    Chief Growth Officer
    Comp: $997.28k
  • Ms. Anna Shlimak (Age 38)
    Senior Vice President of Corporate Affairs & Strategy
    Comp: $724.62k
  • Mr. James Andrew McGinness III (Age 45)
    VP, Controller & Principal Accounting Officer
  • Mr. Shayne J. Laidlaw
    Director of Investor Relations & Strategy
  • Mr. Terry Gregory-Joseph Doucet (Age 34)
    General Counsel & Corporate Secretary
  • Ms. Shannon Buggy (Age 54)
    Senior VP & Global Head of People
    Comp: $599.38k
  • Mr. Arye Weigensberg (Age 41)
    Senior VP & Head of Research and Development
  • Mr. Adam Wagner
    Senior VP & Head of Cronos Israel

CRON Stock Analysis - Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CRON shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares.
View CRON analyst ratings
or view top-rated stocks.

What is Cronos Group's stock price target for 2024?

2 brokerages have issued 1 year price objectives for Cronos Group's stock. Their CRON share price targets range from C$2.72 to C$2.82. On average, they expect the company's share price to reach C$2.77 in the next twelve months. This suggests that the stock has a possible downside of 21.5%.
View analysts price targets for CRON
or view top-rated stocks among Wall Street analysts.

How have CRON shares performed in 2024?

Cronos Group's stock was trading at C$2.77 at the start of the year. Since then, CRON stock has increased by 27.4% and is now trading at C$3.53.
View the best growth stocks for 2024 here
.

When is Cronos Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our CRON earnings forecast
.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS) and Intel (INTC).

How do I buy shares of Cronos Group?

Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:CRON) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners